Kathryn M Dupnik1, Thomas B Bair2, Andressa O Maia3, Francianne M Amorim3, Marcos R Costa4, Tatjana S L Keesen3, Joanna G Valverde3, Maria do Carmo A P Queiroz5, Lúcio L Medeiros6, Nelly L de Lucena7, Mary E Wilson8, Mauricio L Nobre9, Warren D Johnson1, Selma M B Jeronimo10. 1. Division of Infectious Diseases and Center for Global Health, Weill Cornell Medical College, New York, New York. 2. Iowa Institute for Human Genetics, University of Iowa. 3. Department of Biochemistry. 4. Brain Institute. 5. Hospital Onofre Lopes. 6. Secretaria da Saúde, Mossoró, Rio Grande do Norte. 7. Laboratório Luchiari. 8. Departments of Internal Medicine and Microbiology, University of Iowa and the VA Medical Center, Iowa City. 9. Hospital Giselda Trigueiro, Natal Institute of Tropical Medicine of Rio Grande do Norte, Universidade Federal do Rio Grande do Norte Post-graduate Program in Tropical Medicine, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro National Institute of Science and Technology of Tropical Diseases, Salvador, Bahia, Brazil. 10. Department of Biochemistry Institute of Tropical Medicine of Rio Grande do Norte, Universidade Federal do Rio Grande do Norte National Institute of Science and Technology of Tropical Diseases, Salvador, Bahia, Brazil.
Abstract
BACKGROUND: Leprosy morbidity is increased by 2 pathologic immune reactions, reversal reaction (RR) and erythema nodosum leprosum (ENL). METHODS: To discover host factors related to immune reactions, global transcriptional profiles of peripheral blood mononuclear cells were compared between 11 RR, 11 ENL, and 19 matched control patients, with confirmation by quantitative polymerase chain reaction. Encoded proteins were investigated in skin biopsy specimens by means of immunohistochemistry. RESULTS: There were 275 genes differentially expressed in RR and 517 differentially expressed in ENL on the microarray. Pathway analysis showed immunity-related pathways represented in RR and ENL transcriptional profiles, with the "complement and coagulation" pathway common to both. Interferon γ was identified as a significant upstream regulator of the expression changes for RR and ENL. Immunohistochemical staining of skin lesions showed increased C1q in both RR and ENL. CONCLUSIONS: These data suggest a previously underrecognized role for complement in the pathogenesis of both RR and ENL, and we propose new hypotheses for reaction pathogenesis.
BACKGROUND:Leprosy morbidity is increased by 2 pathologic immune reactions, reversal reaction (RR) and erythema nodosum leprosum (ENL). METHODS: To discover host factors related to immune reactions, global transcriptional profiles of peripheral blood mononuclear cells were compared between 11 RR, 11 ENL, and 19 matched control patients, with confirmation by quantitative polymerase chain reaction. Encoded proteins were investigated in skin biopsy specimens by means of immunohistochemistry. RESULTS: There were 275 genes differentially expressed in RR and 517 differentially expressed in ENL on the microarray. Pathway analysis showed immunity-related pathways represented in RR and ENL transcriptional profiles, with the "complement and coagulation" pathway common to both. Interferon γ was identified as a significant upstream regulator of the expression changes for RR and ENL. Immunohistochemical staining of skin lesions showed increased C1q in both RR and ENL. CONCLUSIONS: These data suggest a previously underrecognized role for complement in the pathogenesis of both RR and ENL, and we propose new hypotheses for reaction pathogenesis.
Authors: Huyen T T Tran; Rafael Van den Bergh; Marguerite M Loembé; William Worodria; Harriet Mayanja-Kizza; Robert Colebunders; Françoise Mascart; Patrick Stordeur; Luc Kestens; Patrick De Baetselier; Geert Raes Journal: AIDS Date: 2013-07-17 Impact factor: 4.177
Authors: Anselmo Alves Lustosa; Lídya Tolstenko Nogueira; José Ivo dos Santos Pedrosa; João Batista Mendes Teles; Viriato Campelo Journal: Rev Soc Bras Med Trop Date: 2011-10 Impact factor: 1.581
Authors: Ana Lucia M Sousa; Vinicius M Fava; Lucas H Sampaio; Celina Maria T Martelli; Mauricio B Costa; Marcelo T Mira; Mariane M A Stefani Journal: J Infect Dis Date: 2012-03-29 Impact factor: 5.226
Authors: David M Scollard; Meher V Chaduvula; Alejandra Martinez; Natalie Fowlkes; Indira Nath; Barbara M Stryjewska; Michael T Kearney; Diana L Williams Journal: Clin Vaccine Immunol Date: 2011-04-20
Authors: Rosane M B Teles; Thomas G Graeber; Stephan R Krutzik; Dennis Montoya; Mirjam Schenk; Delphine J Lee; Evangelia Komisopoulou; Kindra Kelly-Scumpia; Rene Chun; Shankar S Iyer; Euzenir N Sarno; Thomas H Rea; Martin Hewison; John S Adams; Stephen J Popper; David A Relman; Steffen Stenger; Barry R Bloom; Genhong Cheng; Robert L Modlin Journal: Science Date: 2013-02-28 Impact factor: 47.728
Authors: Edessa Negera; Stephen L Walker; Tsehaynesh Lema; Abraham Aseffa; Diana N Lockwood; Hazel M Dockrell Journal: PLoS Negl Trop Dis Date: 2018-03-02
Authors: Nawal Bahia El Idrissi; Anand M Iyer; Valeria Ramaglia; Patricia S Rosa; Cleverson T Soares; Frank Baas; Pranab K Das Journal: PLoS One Date: 2017-05-15 Impact factor: 3.240
Authors: Gabriela Canalli Kretzschmar; Luana Caroline Oliveira; Renato Mitsunori Nisihara; Thirumalaisamy P Velavan; Sérvio Túlio Stinghen; Ewalda R S Stahlke; Maria Luiza Petzl-Erler; Iara José T de Messias-Reason; Angelica Beate Winter Boldt Journal: PLoS Negl Trop Dis Date: 2018-08-09
Authors: Rosalie Lubbers; Jayne S Sutherland; Delia Goletti; Roelof A de Paus; Coline H M van Moorsel; Marcel Veltkamp; Stefan M T Vestjens; Willem J W Bos; Linda Petrone; Franca Del Nonno; Ingeborg M Bajema; Karin Dijkman; Frank A W Verreck; Gerhard Walzl; Kyra A Gelderman; Geert H Groeneveld; Annemieke Geluk; Tom H M Ottenhoff; Simone A Joosten; Leendert A Trouw Journal: Front Immunol Date: 2018-10-23 Impact factor: 7.561
Authors: Roberta Olmo Pinheiro; Veronica Schmitz; Bruno Jorge de Andrade Silva; André Alves Dias; Beatriz Junqueira de Souza; Mayara Garcia de Mattos Barbosa; Danuza de Almeida Esquenazi; Maria Cristina Vidal Pessolani; Euzenir Nunes Sarno Journal: Front Immunol Date: 2018-03-28 Impact factor: 7.561